Fluticasone-Salmeterol Drug Combination
"Fluticasone-Salmeterol Drug Combination" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A drug combination of fluticasone and salmeterol that is used as an inhaler formulation to manage the symptoms of ASTHMA and CHRONIC OBSTRUCTIVE PULMONARY DISEASE.
| Descriptor ID |
D000068297
|
| MeSH Number(s) |
D02.033.100.291.057.750.500 D02.092.063.291.057.750.500 D02.092.471.683.061.750.500 D04.210.500.054.079.129.114.500 D26.310.438
|
| Concept/Terms |
Fluticasone-Salmeterol Drug Combination- Fluticasone-Salmeterol Drug Combination
- Drug Combination, Fluticasone-Salmeterol
- Fluticasone Salmeterol Drug Combination
- Fluticasone - Salmeterol
- Fluticasone Salmeterol
- Fluticasone-Salmeterol Combination
- Combination, Fluticasone-Salmeterol
- Fluticasone Salmeterol Combination
Fluticasone Propionate, Salmeterol Xinafoate Drug Combination- Fluticasone Propionate, Salmeterol Xinafoate Drug Combination
- Fluticasone Propionate-Salmeterol Xinafoate Combination
- Fluticasone Propionate Salmeterol Xinafoate Combination
- Fluticasone Propionate-Salmeterol Drug Combination
- Fluticasone Propionate Salmeterol Drug Combination
- Fluticasone Propionate - Salmeterol Combination
- Fluticasone Propionate Salmeterol Combination
- Fluticasone Propionate-Salmeterol Xinafoate Drug Combination
- Fluticasone Propionate Salmeterol Xinafoate Drug Combination
- Fluticasone Propionate - Salmeterol Xinafoate
- Fluticasone Propionate Salmeterol Xinafoate
- Fluticasone Propionate - Salmeterol
- Fluticasone Propionate Salmeterol
|
Below are MeSH descriptors whose meaning is more general than "Fluticasone-Salmeterol Drug Combination".
Below are MeSH descriptors whose meaning is more specific than "Fluticasone-Salmeterol Drug Combination".
This graph shows the total number of publications written about "Fluticasone-Salmeterol Drug Combination" by people in this website by year, and whether "Fluticasone-Salmeterol Drug Combination" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2011 | 0 | 1 | 1 |
| 2014 | 0 | 1 | 1 |
| 2016 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Fluticasone-Salmeterol Drug Combination" by people in Profiles.
-
Rennard SI, Martinez FJ, Rabe KF, Sethi S, Pizzichini E, McIvor A, Siddiqui S, Anzueto A, Zhu H. Effects of roflumilast in COPD patients receiving inhaled corticosteroid/long-acting ?2-agonist fixed-dose combination: RE(2)SPOND rationale and study design. Int J Chron Obstruct Pulmon Dis. 2016; 11:1921-8.
-
Dransfield MT, Feldman G, Korenblat P, LaForce CF, Locantore N, Pistolesi M, Watkins ML, Crim C, Martinez FJ. Efficacy and safety of once-daily fluticasone furoate/vilanterol (100/25 mcg) versus twice-daily fluticasone propionate/salmeterol (250/50 mcg) in COPD patients. Respir Med. 2014 Aug; 108(8):1171-9.
-
Dransfield MT, Cockcroft JR, Townsend RR, Coxson HO, Sharma SS, Rubin DB, Emmett AH, Cicale MJ, Crater GD, Martinez FJ. Effect of fluticasone propionate/salmeterol on arterial stiffness in patients with COPD. Respir Med. 2011 Sep; 105(9):1322-30.